JP2022536655A5 - - Google Patents
Info
- Publication number
- JP2022536655A5 JP2022536655A5 JP2021573245A JP2021573245A JP2022536655A5 JP 2022536655 A5 JP2022536655 A5 JP 2022536655A5 JP 2021573245 A JP2021573245 A JP 2021573245A JP 2021573245 A JP2021573245 A JP 2021573245A JP 2022536655 A5 JP2022536655 A5 JP 2022536655A5
- Authority
- JP
- Japan
- Prior art keywords
- inventions described
- inventions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019090714 | 2019-06-11 | ||
| CNPCT/CN2019/090714 | 2019-06-11 | ||
| PCT/US2020/037233 WO2020252165A1 (en) | 2019-06-11 | 2020-06-11 | Quinazolinyl compounds and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022536655A JP2022536655A (ja) | 2022-08-18 |
| JP2022536655A5 true JP2022536655A5 (enExample) | 2023-06-19 |
| JP7765972B2 JP7765972B2 (ja) | 2025-11-07 |
Family
ID=71409497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021573245A Active JP7765972B2 (ja) | 2019-06-11 | 2020-06-11 | キナゾリニル化合物及び使用方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20220249487A1 (enExample) |
| EP (1) | EP3983400B1 (enExample) |
| JP (1) | JP7765972B2 (enExample) |
| CN (1) | CN114302877A (enExample) |
| WO (1) | WO2020252165A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116710429A (zh) * | 2020-11-13 | 2023-09-05 | 加利福尼亚大学董事会 | IRE1α抑制剂及其用途 |
| PE20231311A1 (es) | 2020-11-18 | 2023-08-24 | Deciphera Pharmaceuticals Llc | Inhibidores de gcn2 y perk quinasas y metodos de uso de los mismos |
| MX2024006627A (es) | 2021-12-03 | 2024-08-22 | Deciphera Pharmaceuticals Llc | Inhibidores de gcn2 y perk quinasa y metodos de uso de los mismos. |
| WO2024131893A1 (en) * | 2022-12-22 | 2024-06-27 | Shanghai Yi Zhong Xing Biotechnology Co., Ltd. | IRE1α SMALL MOLECULE INHIBITORS |
| WO2026136623A1 (en) | 2024-12-19 | 2026-06-25 | Genentech, Inc. | Ire1 degrader compounds and methods of use |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US5543523A (en) | 1994-11-15 | 1996-08-06 | Regents Of The University Of Minnesota | Method and intermediates for the synthesis of korupensamines |
| EP1751136B1 (en) | 2004-05-07 | 2014-07-02 | Amgen Inc. | Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| US20070054916A1 (en) | 2004-10-01 | 2007-03-08 | Amgen Inc. | Aryl nitrogen-containing bicyclic compounds and methods of use |
| US7868177B2 (en) | 2006-02-24 | 2011-01-11 | Amgen Inc. | Multi-cyclic compounds and method of use |
| CN104230901A (zh) | 2008-09-15 | 2014-12-24 | 加利福尼亚大学董事会 | 用于调节ire1、src和abl活性的方法和组合物 |
| WO2016004254A1 (en) | 2014-07-01 | 2016-01-07 | The Regents Of The University Of California | Combined modulation of ire1 |
| WO2018102751A1 (en) | 2016-12-02 | 2018-06-07 | Quentis Therapeutics, Inc. | Ire1 small molecule inhibitors |
| US10392367B2 (en) * | 2017-06-01 | 2019-08-27 | Quentis Therapeutics, Inc. | IRE1 small molecule inhibitors |
| AU2018278311B2 (en) * | 2017-06-01 | 2021-10-07 | Cornell University | IRE1 small molecule inhibitors |
| WO2018222917A1 (en) | 2017-06-01 | 2018-12-06 | Quentis Therapeutics, Inc. | Ire1 small molecule inhibitors |
| WO2019094641A1 (en) | 2017-11-10 | 2019-05-16 | Quentis Therapeutics, Inc. | Ire1 small molecule inhibitors |
| JP7546299B2 (ja) * | 2018-12-03 | 2024-09-06 | コーネル・ユニバーシティー | Ｉｒｅ１小分子阻害物質 |
-
2020
- 2020-06-11 EP EP20735729.4A patent/EP3983400B1/en active Active
- 2020-06-11 CN CN202080043395.7A patent/CN114302877A/zh active Pending
- 2020-06-11 JP JP2021573245A patent/JP7765972B2/ja active Active
- 2020-06-11 WO PCT/US2020/037233 patent/WO2020252165A1/en not_active Ceased
-
2021
- 2021-12-10 US US17/643,623 patent/US20220249487A1/en active Pending